Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
In the last decade, advances in the understanding of lipoprotein and lipid metabolism have developed enormously. This has resulted in a detailed knowledge of the mechanisms underlying the primary and secondary dyslipidaemias. Furthermore, the role of lipoproteins in atherogenesis is increasingly understood at the cellular and molecular level. In this book, the scale of the problem of cardiovascular disease (CVD) is described together with the possibilities for prevention. The pathophysiology of lipid and lipoproteins provide a background to the understanding of the primary and secondary dyslipidaemias and the mechanism of action of the different drug classes.A practical approach to therapy is provided including diet, lifestyle, and therapeutic approaches. Common clinical problems are addressed and the book looks to the future, principally in relation to new therapeutic targets. This book provides the basis for the translation of clinical trial science into everyday clinical practice for the benefit of the individual patient.
1. Epidemiology of cardiovascular disease: the scale of the problem ; 2. Lipids, lipoproteins and atherogenesis ; 3. Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN and QRISK ; 4. Primary dyslipidaemias ; 5. Secondary dyslipidemias ; 6. Diet and lifestyle ; 7. Pharmacological therapy: Statins ; 8. Pharmacological therapy: Non-Statin Drugs ; 9. Combination therapy for the management of hyperlipidaemia ; 10. Recent lipid-lowering trials in perspective: Implications for therapy ; 11. Vascular imaging ; 12. Common problems in lipid management
Andrea Rubboli, Eric Eeckhout, Gregory Lip, Italy) Rubboli, Andrea (Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Bologna, Switzerland) Eeckhout, Eric (Division of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, UK) Lip, Gregory (University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham
Mohammad Shenasa, A. John Camm, USA) Shenasa, Mohammad (Attending Physician, Attending Physician, Department of Cardiovascular Services, O'Connor Hospital, Heart & Rhythm Medical Group, San Jose, California, UK) Camm, A. John (Professor of Clinical Cardiology, Professor of Clinical Cardiology, Department of Clinical Sciences, St. George's and University of London , London, A John Camm
Derek Hausenloy, Derek Yellon, UK) Hausenloy, Derek (Clinical Research Fellow, Hatter Cardiovascular Institute, University College London Hospital, UK) Yellon, Derek (Clinical Research Fellow, Hatter Cardiovascular Institute, University College London Hospital
Petr Widimsky, Harry Suryapranata, Alec Vahanian, Jozef Masura, Czech Republic) Widimsky, Petr (Head of the Cardiology & Cardiac Surgery Centre, University Hospital Kralovske Vinohrady, Prague, The Netherlands) Suryapranata, Harry (Consultant Cardiologist, Isala Klinieken, Zwolle, France) Vahanian, Alec (Head of the Cardiology Deptartment, University Hospital Bichat, Paris, Slovakia) Masura, Jozef (Head of Pediatric Interventional cardiology unit, University hospital Bratislava